(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -2.21%1.71B | -21.30%986.42M | -32.91%463.5M | -7.58%2.28B | -18.68%1.75B | -13.95%1.25B | 5.37%690.86M | 15.39%2.47B | 28.74%2.15B | 62.51%1.46B |
Refunds of taxes and levies | -15.63%117.93M | -10.69%75.78M | -1.43%42.32M | -28.72%187.59M | -29.53%139.78M | -40.41%84.85M | -22.48%42.93M | 104.53%263.16M | 121.32%198.35M | 160.06%142.38M |
Net deposit increase | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net increase in borrowings from central bank | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net increase in placements from other financial institutions | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash received from interests, fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net increase in repurchase business capital | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Premiums received from original insurance contracts | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net cash received from reinsurance business | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net increase in deposits from policyholders | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net increase in funds disbursed | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net cash received from trading securities | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash received relating to other operating activities | -85.03%21.27M | -18.83%18.29M | 4.12%29.78M | -46.14%35.18M | 410.62%142.08M | 60.31%22.53M | 299.70%28.6M | 67.54%65.33M | -26.25%27.82M | -34.63%14.06M |
Adjustment items of operating cash inflws | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
Cash inflows from operating activities | -8.93%1.85B | -20.60%1.08B | -29.75%535.59M | -10.47%2.5B | -14.56%2.03B | -15.64%1.36B | 6.15%762.39M | 21.25%2.8B | 32.20%2.38B | 65.85%1.61B |
Goods services cash paid | -14.85%1.22B | -28.71%762.38M | -25.05%391.76M | -0.84%1.72B | -11.27%1.43B | -9.01%1.07B | -2.35%522.69M | -8.32%1.74B | -1.44%1.61B | 32.16%1.18B |
Staff behalf paid | 7.15%249.87M | 0.87%172.82M | -0.78%98.97M | 10.62%301.8M | 15.44%233.2M | 16.48%171.33M | 27.05%99.74M | 5.68%272.84M | 14.02%202M | 23.35%147.09M |
All taxes paid | -47.07%55.48M | -38.17%44.3M | -59.89%14.56M | 17.95%143.77M | 31.34%104.83M | 32.72%71.66M | 73.00%36.29M | 37.03%121.89M | 39.28%79.81M | 31.00%53.99M |
Net loan and advance increase | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net deposit in central bank and institutions | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Net lend capital | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash paid for fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Policy dividend cash paid | --0 | --0 | --0 | ---- | --0 | --0 | ---- | ---- | ---- | ---- |
Cash paid relating to other operating activities | 1.01%167.73M | -37.25%99.62M | -31.72%66.07M | -25.72%166.27M | 7.57%166.05M | 94.49%158.74M | 31.04%96.75M | 11.78%223.84M | 18.54%154.36M | -18.29%81.62M |
Adjustment items of operating cash outflws | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
Cash outflows from operating activities | -12.59%1.69B | -26.65%1.08B | -24.37%571.36M | -0.90%2.34B | -5.57%1.94B | 0.90%1.47B | 6.62%755.49M | -3.54%2.36B | 2.39%2.05B | 26.82%1.46B |
Net cash flows from operating activities | 65.81%157.2M | 101.25%1.38M | -617.85%-35.76M | -61.85%167.55M | -70.99%94.81M | -171.21%-110.33M | -28.34%6.91M | 419.59%439.12M | 259.95%326.83M | 187.46%154.94M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 226.32%620M | 211.11%280M | --124.25M | -30.29%370M | -64.15%190M | -77.50%90M | --0 | -19.21%530.78M | -47.74%530M | -58.26%400M |
Cash received from returns on investments | 133.17%5.37M | 323.23%3.61M | 341.05%156.2K | -5.90%5.08M | -46.75%2.3M | -73.25%853.36K | -98.43%35.42K | -59.61%5.4M | -63.59%4.32M | -68.03%3.19M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 5,144.26%16.28M | 61,835.73%16.26M | 34,234.74%2.78M | -67.23%567.91K | -62.81%310.46K | -95.67%26.26K | -89.20%8.1K | -45.74%1.73M | 493.69%834.87K | 485.34%606.59K |
Net cash received from disposal of subsidiaries and other business units | --7.19M | --0 | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- |
Cash received relating to other investing activities | --0 | --0 | --0 | --100.51M | --0 | ---- | --1.09M | ---- | --0 | ---- |
Cash inflows from investing activities | 236.86%648.84M | 229.97%299.87M | 11,117.31%127.18M | -11.48%476.16M | -64.01%192.61M | -77.49%90.88M | -99.62%1.13M | -20.14%537.92M | -47.85%535.16M | -58.30%403.8M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 115.76%210.19M | 140.78%159.56M | 384.31%88.4M | 106.49%188.21M | 148.58%97.42M | 106.65%66.27M | 23.39%18.25M | 37.41%91.15M | 14.61%39.19M | 47.05%32.07M |
Cash paid to acquire investments | 39.37%613.23M | -23.53%260M | -53.58%116.05M | 165.22%610M | 91.30%440M | 47.83%340M | 8.70%250M | -28.31%230M | -71.28%230M | -67.99%230M |
Net cash paid to acquire subsidiaries and other business units | --0 | --0 | ---- | ---- | -53.40%55.91M | -53.40%55.91M | ---- | 542.22%119.98M | --119.98M | --119.98M |
Impawned loan net increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | ---- |
Cash paid relating to other investing activities | --0 | --0 | --0 | 385.77%19.07M | -96.67%68.8K | -93.27%68.8K | --0 | -93.29%3.93M | 2,461.63%2.07M | 1,424.79%1.02M |
Cash outflows from investing activities | 38.76%823.42M | -9.24%419.56M | -23.79%204.44M | 83.64%817.28M | 51.67%593.4M | 20.67%462.25M | 9.58%268.25M | -4.16%445.05M | -53.16%391.24M | -48.26%383.07M |
Net cash flows from investing activities | 56.44%-174.59M | 67.77%-119.68M | 71.08%-77.26M | -467.33%-341.12M | -378.48%-400.79M | -1,891.53%-371.37M | -564.22%-267.12M | -55.61%92.86M | -24.65%143.92M | -90.91%20.73M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | ---- |
Cash from borrowing | -20.00%300M | -86.67%50M | -64.29%50M | -0.51%475M | -12.27%375M | 25.65%375M | 92.12%140M | 278.54%477.46M | 327.46%427.46M | 326.37%298.46M |
Cash received relating to other financing activities | -37.06%237.03M | -56.04%148.39M | 65.37%258.38M | 385.14%522.75M | 208.33%376.6M | 222.18%337.52M | 56.62%156.24M | 8.71%107.75M | 52.26%122.14M | 71.54%104.76M |
Cash inflows from financing activities | -28.55%537.03M | -72.16%198.39M | 4.10%308.38M | 70.50%997.75M | 36.75%751.6M | 76.71%712.52M | 71.60%296.24M | 124.25%585.21M | 154.53%549.6M | 207.63%403.22M |
Borrowing repayment | -12.39%326.77M | -79.89%75M | -96.99%1.77M | 16.02%473M | 9.06%373M | 195.26%373M | 47.50%59M | 182.70%407.68M | 194.45%342M | 46.64%126.33M |
Dividend interest payment | 13.80%79.64M | 14.86%77.84M | 237.52%6.23M | 4.98%73.29M | 3.81%69.98M | 5.67%67.77M | 29.54%1.85M | 62.20%69.81M | 62.76%67.41M | 61.00%64.13M |
-Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | --0 | ---- |
Cash payments relating to other financing activities | -55.41%174.48M | -41.73%143.14M | 132.05%203.9M | 470.17%595.44M | 168.93%391.34M | 114.04%245.67M | 13.76%87.87M | -14.41%104.43M | 65.01%145.52M | 31.31%114.77M |
Cash outflows from financing activities | -30.38%580.89M | -56.88%295.98M | 42.49%211.91M | 96.20%1.14B | 50.35%834.32M | 124.88%686.44M | 25.33%148.72M | 88.16%581.92M | 125.81%554.93M | 43.04%305.24M |
Net cash flows from financing activities | 46.98%-43.86M | -474.14%-97.6M | -34.61%96.47M | -4,480.51%-143.97M | -1,451.23%-82.72M | -73.38%26.09M | 173.37%147.52M | 106.80%3.29M | 82.12%-5.33M | 219.02%97.98M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -2.85%3.54M | -51.48%1.69M | 60.79%-2.18M | -70.20%6.79M | -86.09%3.65M | -74.21%3.47M | -292.00%-5.56M | 1,012.89%22.79M | 3,897.30%26.22M | 2,733.24%13.47M |
Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- |
Net increase in cash and cash equivalents | 85.02%-57.7M | 52.62%-214.21M | 84.15%-18.74M | -155.68%-310.75M | -178.32%-385.06M | -257.47%-452.14M | -198.77%-118.25M | 2,557.18%558.06M | 1,221.33%491.64M | 998.47%287.12M |
Add:Begin period cash and cash equivalents | -33.48%617.4M | -33.48%617.4M | -33.90%617.4M | 150.79%928.15M | 150.79%928.15M | 150.79%928.15M | 162.48%933.97M | 10.53%370.09M | 10.53%370.09M | 10.53%370.09M |
End period cash equivalent | 3.06%559.7M | -15.30%403.18M | -26.61%598.66M | -33.48%617.4M | -36.98%543.1M | -27.57%476.01M | 71.53%815.72M | 160.85%928.15M | 196.15%861.73M | 117.00%657.21M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data